
Cancer Risk & Early Detection
The earlier cancer is detected, the more treatable it becomes — and waiting for symptoms is the most expensive way to find out.
Why this assessment
This assessment combines advanced early-detection screening with personalised risk modelling to reveal hidden risk long before symptoms appear. It is designed for people who want the earliest possible warning signal and a screening plan built around their own biology, not a generic age chart.
- Anyone over 40, or younger with a family history of cancer
- People who want screening earlier and more precisely than routine care offers
- Survivors monitoring for recurrence alongside their oncology team
- Executives who want the earliest possible warning signal
What we measure, and why it matters.
A single blood test screening for signals shared across dozens of cancer types, many with no routine screening programme.
Detects disease at a stage where treatment is most effective — often years before symptoms appear.
Detects fragments of tumour DNA shed into the bloodstream.
Non-invasive, highly sensitive, and useful both for early detection and for monitoring after treatment.
Established protein markers such as PSA, CA-125, CEA, AFP and CA 19-9, interpreted in clinical context.
Adds organ-specific detail and provides a baseline to track over time rather than a one-off snapshot.
Combines family history, genetics, lifestyle, metabolic status and inflammation into an individualised risk model.
Determines which scans and screens you actually need, and how frequently — targeted rather than generic.
A clear risk picture and a personalised screening calendar reviewed with a physician, with onward referral pathways if anything needs urgent attention.
